RCKT (Rocket Pharmaceuticals) Short Ratio


RCKT Rocket Pharmaceuticals Inc RCKT
21 GF Score
Price $4.16
! 3 Warning Signs
View Full Analysis

What is Rocket Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RCKT
21GF Score
Rocket Pharmaceuticals Inc RCKT
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Pharmaceuticals Business Description

Other Exchanges 9IP1:Germany
Address 9 Cedarbrook Drive, Cranbury, NJ, USA, 08512
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
21GF Score

Get the complete analysis for RCKT

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.16
Price